Department of Pharmacology & Therapeutics, College of Pharmacy/University of Jabbir ibn Hayyan, Iraq
Research
Metformin lowers both liver and kidney tests in women with diabetes melts type 2 in the mid-Euphrates of Iraq
Author(s): Ali A. R. Aldallal, Heba A. Abd-Alsalam Alsalame, Hafidh I. Al-Sadi, Ghasaq Jafaar Sadeq, Zainab Ali Hussein and Saif M. Hassan*
Introduction: Diabetes is a metabolic disease characterised by hyperglycaemia resulting from defects in insulin secretion, action, or both. It is currently the third most detrimental chronic illness to human health. The prevalence of diabetes is increasing globally due to factors such as improved living standards, urbanization, industrialization, and an ageing population. According to the WHO, the present global prevalence of diabetes is approximately 422 million, and this figure is projected to rise to 600 million by 2040.
Methods: A retrospective cross-sectional study was conducted on 200 women with type 2 diabetes mellitus (T2DM). The participants were divided into two groups based on their utilisation of metformin. The Met group (MG) comprised 50 women who had been administered 500 mg of metformin twice daily, while the non-Met g.. Read More»